Quantcast
Last updated on April 21, 2014 at 11:58 EDT

Latest Vagus nerve stimulation Stories

2012-09-20 06:31:08

HOUSTON, Sept. 20, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced an initial investment of EUR 2 million in cerbomed GmbH ("cerbomed"). Based in Erlangen, Germany, cerbomed is a privately-held company developing a non-invasive neurostimulation device for the treatment of epilepsy. The NEMOS(®) t-VNS device received CE Mark approval for the treatment of epilepsy and depression in 2010...

2012-09-12 23:02:26

Physicians at the Cardiovascular Institute of Allegheny General Hospital in Pittsburgh have launched a study exploring the potential of an investigational, implantable device to determine whether stimulation of a critical nerve pathway in the brain can relieve the symptoms of heart failure and slow disease progression. Heart failure is a leading cause of death and disability in the United States and the leading cause of hospital admissions in adults over the age of 65. Pittsburgh, PA (PRWEB)...

2012-09-06 02:32:39

HOUSTON, Sept. 6, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences in September. Greg Browne, Cyberonics' Chief Financial Officer, will present at the UBS Global Life Sciences Conference on Wednesday, September 19, 2012 at 3:00 PM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link...

2012-08-30 10:25:03

HOUSTON, Aug. 30, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the Morgan Stanley Global Healthcare Conference on Monday, September 10, 2012, in New York. Dan Moore, Cyberonics' President and Chief Executive Officer, will speak at 1:50 PM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the...

2012-07-20 01:41:22

UT Dallas researchers recently demonstrated how nerve stimulation paired with specific experiences, such as movements or sounds, can reorganize the brain. This technology could lead to new treatments for stroke, tinnitus, autism and other disorders. In a related paper, UT Dallas neuroscientists showed that they could alter the speed at which the brain works in laboratory animals by pairing stimulation of the vagus nerve with fast or slow sounds. A team led by Dr. Robert Rennaker and...

2012-06-12 10:22:30

Study of 779 patients with sleep apnea sees improvement for all, even those failing to use positive airway pressure as prescribed Patients seen at the Cleveland Clinic Sleep Disorders Center who used positive airway pressure (PAP) to treat their obstructive sleep apnea (OSA) had improvements in their depressive symptoms, even if they followed the prescribed PAP regimen only partly, a new study reports. The study looked at 779 patients with OSA and asked them to fill out a standardized...

2012-06-11 02:26:01

HOUSTON, June 11, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX) today announced that it has entered into an exclusive technology license agreement with Imricor Medical Systems, Inc. to develop Magnetic Resonance Imaging ("MRI") compatible leads for use with the VNS Therapy® System (Vagus Nerve Stimulation). Imricor Medical Systems, based in Burnsville, Minnesota, is developing innovative MRI electrophysiology tools and has developed the world's only ablation catheter that is...

2012-06-06 22:20:59

LOUVAIN LA NEUVE, Belgium, June 7, 2012 /PRNewswire/ -- Treatment of Refractory Epilepsy by Vagus Nerve Stimulation to be available in Europe Neurotech s.a. (http://www.neurotech-int.eu), a Belgium based developer and manufacturer of neurostimulation devices, announces that it has obtained the European CE Mark for its ADNS-300 system dedicated to the treatment of refractory epilepsy. The surgically implanted ADNS-300 system delivers mild electrical pulses to the vagus...

2012-05-24 02:28:29

HOUSTON, May 24, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the Jefferies 2012 Global Healthcare Conference on Thursday, June 7, 2012, in New York. Greg Browne, Senior Vice President and Chief Financial Officer, will speak at 10:00 AM Eastern Time. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the...

2012-05-23 02:26:51

HOUSTON, May 23, 2012 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ: CYBX) today announced that company co-founder, Reese S. Terry, Jr., is the recipient of the 2012 Professional Career Achievement Award from the Institute of Electrical and Electronic Engineers (IEEE) Engineering in Medicine & Biology Society. The award recognizes his significant contributions to therapeutic implantable devices and procedures for the treatment of epilepsy and drug-resistant chronic depression. Mr. Terry...